Scinvivo Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
Scinvivo General Information
Description
Developer of a minimally invasive imaging platform designed to advance cancer diagnostics and care. The company's technology provides real-time visualization of subsurface tissue structures during endoscopic procedures, addressing limitations of conventional imaging methods and enabling medical professionals to improve diagnostic accuracy and treatment outcomes.
Contact Information
Website
www.scinvivo.comCorporate Office
- Torenallee 20
- 5617 BC Eindhoven
- Netherlands
Corporate Office
- Torenallee 20
- 5617 BC Eindhoven
- Netherlands
Scinvivo Timeline
Scinvivo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 30-Oct-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 21-Feb-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 10-Mar-2022 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 22-Dec-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 08-Oct-2019 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 22-Mar-2017 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Scinvivo Patents
Scinvivo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4522936-A1 | Optical coherence tomography system and method | Pending | 10-May-2022 | ||
| US-12768640-B2 | Optical coherence tomography system and method | Active | 10-May-2022 | ||
| US-20250297850-A1 | Optical coherence tomography system and method | Active | 10-May-2022 | ||
| WO-2023219501-A1 | Optical coherence tomography system and method | Inactive | 10-May-2022 | ||
| EP-3761858-A1 | Mems mirror for oct probe and method of manufacturing such mems mirror | Active | 09-Mar-2018 | G02B26/0841 |
Scinvivo Signals
Scinvivo Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Texas Medical Center | Venture Capital | Minority | ||
| Rijksdienst voor Ondernemend Nederland | Government | Minority | ||
| Santec OIS Corporation | Corporation | Minority | ||
| Innovatiefonds Noord-Holland | Venture Capital | Minority | ||
| Reno Seed Advisors | Venture Capital | Minority |
Scinvivo FAQs
-
When was Scinvivo founded?
Scinvivo was founded in 2016.
-
Where is Scinvivo headquartered?
Scinvivo is headquartered in Eindhoven, Netherlands.
-
What is the size of Scinvivo?
Scinvivo has 8 total employees.
-
What industry is Scinvivo in?
Scinvivo’s primary industry is Diagnostic Equipment.
-
Is Scinvivo a private or public company?
Scinvivo is a Private company.
-
What is Scinvivo’s current revenue?
The current revenue for Scinvivo is .
-
How much funding has Scinvivo raised over time?
Scinvivo has raised $6.2M.
-
Who are Scinvivo’s investors?
Texas Medical Center, Rijksdienst voor Ondernemend Nederland, Santec OIS Corporation, Innovatiefonds Noord-Holland, and Reno Seed Advisors are 5 of 9 investors who have invested in Scinvivo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process